Exactech Innovations Presented at Recent Key Scientific Conferences

Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, recounted today the significant number of scientific posters and presentations regarding its latest advancements for knee, hip and shoulder replacement surgery that have been presented during key medical technology conferences over the past month.

“We are proud of the strong presence Exactech innovations have at important scientific symposiums,” said Gary Miller, Ph.D., Exactech’s executive vice president of Research and Development. “Our technologies have been featured in 17 posters and papers over the past month alone. This is just one example of Exactech’s ongoing commitment to improving patient outcomes by advancing the technology available to orthopaedic surgeons around the world.”

International Scientific Presentations Feature Exactech Hip and Knee Innovations

During the International Congress for Joint Replacement’s (ICJR) Transatlantic Orthopaedic Congress in New York, Oct. 3-5, Pasquale Petrera, MD, presented “Navigated Total Knee Arthroplasty is No Slower than Conventional Instrumented TKA.” This study documents Dr. Petrera’s clinical experience with ExactechGPS®, the company’s guided, personalized surgery system.

ExactechGPS was also the subject of lectures presented at the Korean national symposium on computer assisted orthopaedic surgery, CAOS-Korea 2014, Sept. 19. The program included a presentation co-authored by Ralph Liebelt, MD, on the use of the image-free computer assisted guidance system.

Two presentations and six e-posters on hip and knee implant design, materials and instrumentation, including ExactechGPS, were featured at the International Society for Technology (ISTA) in Arthroplasty, Sept. 24-27 in Japan.

Shoulder Courses Feature Exactech’s Equinoxe® Shoulder System

The third annual Shoulder Course by the International Congress for Joint Reconstruction (ICJR) held in Las Vegas, Sept. 18-20, featured four lectures on the use of Exactech’s Equinoxe® platform shoulder system. Emilie Cheung, MD, Richard Friedman, MD, FRCSC, and Howard Routman, DO, shared their clinical experiences using the Equinoxe shoulder to address glenoid management, reverse total shoulder arthroplasty and revision shoulder surgery.

Exactech’s shoulder system was also featured in podium presentations by Pierre-Henri Flurin, MD, at the European Society for Surgery of the Shoulder and the Elbow (also known as SECEC) 2014, Sept. 17-20 in Istanbul.

To learn more about Exactech’s latest innovations, orthopaedic surgeons can participate in the many medical education programs featured on Exactech’s website.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.